• The Antidote

  • Inside the World of New Pharma
  • De: Barry Werth
  • Narrado por: Sean Pratt
  • Duración: 16 h y 27 m
  • 4.1 out of 5 stars (75 calificaciones)

Escucha audiolibros, podcasts y Audibles Originals con Audible Plus por un precio mensual bajo.
Escucha en cualquier momento y en cualquier lugar en tus dispositivos con la aplicación gratuita Audible.
Los suscriptores por primera vez de Audible Plus obtienen su primer mes gratis. Cancela la suscripción en cualquier momento.
The Antidote  Por  arte de portada

The Antidote

De: Barry Werth
Narrado por: Sean Pratt
Prueba por $0.00

Escucha con la prueba gratis de Plus

Compra ahora por US$18.05

Compra ahora por US$18.05

la tarjeta con terminación
Al confirmar tu compra, aceptas las Condiciones de Uso de Audible y el Aviso de Privacidad de Amazon. Impuestos a cobrar según aplique.

Resumen del Editor

In 1989, the charismatic Joshua Boger left Merck, then America's most admired business, to found a drug company that would challenge industry giants and transform health care. Barry Werth described the company's tumultuous early days during the AIDS crisis in The Billion-Dollar Molecule, a celebrated classic of science and business journalism. Now he returns to tell a riveting story of Vertex's bold endurance and eventual success.

The $325-billion-a-year pharmaceutical business is America's toughest and one of its most profitable. It is riskier and more rigorous at just about every stage than any other business, from the towering biological uncertainties inherent in its mission to treat disease; to the 30-to-1 failure rate in bringing out a successful medicine even after a molecule clears all the hurdles to get to human testing; to the multibillion-dollar cost of ramping up a successful product; to operating in the world's most regulated industry, matched only by nuclear power.

Werth captures the full scope of Vertex's 25-year drive to deliver breakthrough medicines. At a time when America struggles to maintain its innovative edge, The Antidote is a powerful inside look at one of the most intriguing and important business stories of recent decades.

©2014 Barry Werth (P)2014 Tantor

Reseñas de la Crítica

"A revealing, readable book about 'some of competitive capitalism's most complicated science and most cutthroat marketing maneuvers.'" (Kirkus)

Lo que los oyentes dicen sobre The Antidote

Calificaciones medias de los clientes
Total
  • 4 out of 5 stars
  • 5 estrellas
    36
  • 4 estrellas
    19
  • 3 estrellas
    12
  • 2 estrellas
    5
  • 1 estrella
    3
Ejecución
  • 4 out of 5 stars
  • 5 estrellas
    29
  • 4 estrellas
    19
  • 3 estrellas
    11
  • 2 estrellas
    2
  • 1 estrella
    3
Historia
  • 4 out of 5 stars
  • 5 estrellas
    32
  • 4 estrellas
    16
  • 3 estrellas
    9
  • 2 estrellas
    5
  • 1 estrella
    3

Reseñas - Selecciona las pestañas a continuación para cambiar el origen de las reseñas.

Ordenar por:
Filtrar por:
  • Total
    5 out of 5 stars
  • Ejecución
    4 out of 5 stars
  • Historia
    5 out of 5 stars

Creating Societal Value

Enjoyed listening to the inside stories about the challenges of creating life enhancing products for humanity. A+

Se ha producido un error. Vuelve a intentarlo dentro de unos minutos.

Has calificado esta reseña.

Reportaste esta reseña

  • Total
    5 out of 5 stars
  • Ejecución
    5 out of 5 stars
  • Historia
    5 out of 5 stars

Development of elegant new medicine

The author brings us inside the finance and science of the development of an entirely new concept in medicine. Vertex looks at chronic illness at the mechanism and focuses on fixing the problem rather than the symptoms. This is the 21st century in health care.

Se ha producido un error. Vuelve a intentarlo dentro de unos minutos.

Has calificado esta reseña.

Reportaste esta reseña

  • Total
    2 out of 5 stars
  • Ejecución
    4 out of 5 stars
  • Historia
    1 out of 5 stars

For me this was not interesting

Sorry for the harsh commentary.... It's like someone compiled all of their stock market announcements into a book, flavored with some irrelevant details about the employees... I was hoping to hear some insights about the pharma market. The book started well.

Se ha producido un error. Vuelve a intentarlo dentro de unos minutos.

Has calificado esta reseña.

Reportaste esta reseña

esto le resultó útil a 1 persona